Migraine

2006 - Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354(24):2552-63  

2002 - Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, Silberstein SD. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002; 22(2):137-141  

2001 - Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, Biason P. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 2001; 21(8):818-822  

2001 - Welch KM, Nagesh V, Aurora SK, Gelman N.Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001; 41(7):629-37  

1998 - Neurology 1998; 50:466-470  

1998 - Wagner W et al. Prophylactic treatment of migraine with gammalinolenic and alpha-linolenic acids. Cephalalgia 1997; 17:127-130.  

1997 - Peikert A et al. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled, double blind randomized study. Cephalalgia 1996;16:257-263.  

1996 - Mauskop A et al. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clinical Science 1995;89:633-636.  

1995 - Schoenen J. et al. Cephalalgia 1994;14:328-329  

1995 - Thys-Jacobs S. Headache 1994;34(9):544-546  

1995 - Magnesium Research 1994;7(2):123-127  

1995 - Schoenen J. et al. Cephalgia 1994;14:328-329